Study finds higher mortality incidence in telemedical monitoring group compared with standard outpatient-monitoring group… Telemonitoring of diabetic foot ulcers involves remotely monitoring patients who are not at the same location as the health care provider. Patients communicate with a specialized ulcer nurse or physician at an outpatient clinic through telephone …
Read More »Dr. Janice Smiell: Biovance and the Future of Chronic Wound Care, Part 2
This week we have the second part of our two-art interview with Dr. Janice Smiell, CMO at Alliqua BioMedical, Inc. Dr. Smiell, and we delve a little deeper into the specifics of this new technology to heal chronic wounds using placental biomaterials. Steve Freed: With all the testing that is …
Read More »Dr. Janice Smiell: Biovance and the Future of Chronic Wound Care, Part 1
This week we are excited about our exclusive interview with Dr. Janice Smiell, CMO at Alliqua BioMedical, Inc. Dr. Smiell and her team have been doing some groundbreaking work on battling chronic wounds using placental biomaterials. Steve Freed: Welcome, Dr. Janice Smiell. Let’s begin by having you tell us a …
Read More »Avoiding Fraud and Waste with Diabetic Therapeutic Footwear
Criteria for a diabetic patient’s therapeutic footwear. Since 1993 Medicare has covered therapeutic shoes for diabetic patients. Within 5 years of the benefit’s availability, a report from the Office of the Inspector General of the United States found that 57% of paid claims had missing or inadequate documentation, while an …
Read More »Vivo Barefoot
From Dave Joffe, Editor-in-chief, Diabetes In Control: Most of us are used to standing on our feet for long hours each day, whether it’s behind a pharmacy counter, going from exam room to exam room, or lecturing in a classroom. At the end of the day nothing feels as …
Read More »How Long Should the Antibiotic Therapy for Nonsurgically Treated Diabetic Foot Osteomyelitis Be?
Six weeks may be just enough…. Little is known about the optimal duration of antibiotic therapy for diabetic foot osteomyelitis (DFO). French researchers compared the effectiveness of 6 versus 12 weeks of antibiotic therapy in patients with DFO treated nonsurgically (i.e., antibiotics alone). This was a prospective randomized trial comparing …
Read More »New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
According to consensus guidelines, relieving pressure on the foot through the use of off-loading improves healing outcomes and reduces complications in patients with diabetic foot ulcers… “The Management of Diabetic Foot Ulcers Through Optimal Off-Loading – Building Consensus Guidelines and Practical Recommendations to Improve Outcomes,” was authored by a multidisciplinary …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #20: Foot Problems in Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP The high-risk diabetic foot The lifetime risk of a person with diabetes developing foot ulceration is around 25%. Recent studies suggest that the population-based incidence of diabetic foot ulcers is 1-4% with a prevalence of 4-10%. The risk of amputation is 10–30-fold …
Read More »New Drug Delivery System to Heal Diabetic Foot Ulcers
Deferoxamine delivered through the skin has the potential to prevent amputations… Stanford University School of Medicine researchers presented results at the American College of Surgeons Annual Clinical Congress showing they have developed a drug delivered via a skin patch that can heal wounds and prevent those wounds from reoccurring. Geoffrey …
Read More »African-Americans More Likely to Have Amputations
Black Americans on Medicare are three times more likely than other patients to lose a leg to amputation because of complications with diabetes and peripheral arterial disease…. Even low-risk black patients with diabetes and peripheral arterial disease faced a higher risk of amputation than most nonblack patients, according to a …
Read More »